European stroke prevention study: effectiveness of antiplatelet therapy in diabetic patients in secondary prevention of stroke.

Open Access
Publisher Website
Google Scholar
Abstract
The aims of this study were to verify that tissue-type plasminogen activator given either 1 or 2 hours after experimental embolic stroke in rabbits diminishes the volume of resulting ischemic brain and to ascertain the effect of the simultaneous administration of heparin.